Medical/Pharmaceuticals
Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology
* Brings Eyenuk's total funding to over $43 million * Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others * Eyenuk adds three new board members * Funding affirms Eyenuk's standing as the global leader among developers of autonomous AI solutions ...
2022-10-17 19:30
2304
Kira Pharmaceuticals to Present First-in-Human Clinical Data at American Society for Nephrology Kidney Week 2022
Phase 1 biomarker data confirms proof of mechanism with dose-dependent and potent inhibition of alternative and terminal pathways with KP104 via dual-targeting mechanism Data demonstrated KP104 was safe and well tolerated, and supports further investigation of KP104 in Phase 2 clinical studies ...
2022-10-17 19:00
3041
Collaboration Between Drug and Medical Food Manufacturers to Boost Market's Growth
Frost & Sullivan says the prevalence of lifestyle diseases and geriatric population drives demand for medical food globally SAN ANTONIO, Oct. 17, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Medical Food Growth Opportunities, finds that the rising consumer awareness about the i...
2022-10-17 17:21
1834
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market
* New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare's immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials * Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve ther...
2022-10-17 13:00
3045
Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese Participants with Overweight or Obesity Published in eClinicalMedicine
ROCKVILLE, Md. and SUZHOU, China, Oct. 17, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major d...
2022-10-17 08:00
5146
Kira Pharmaceuticals Announces IND Approval from Chinese NMPA for Phase 2 Evaluation of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH)
CAMBRIDGE, Mass. and SUZHOU, China, Oct. 17, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) has cleared t...
2022-10-17 07:31
2973
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved an investigational new drug (IND) application to commence...
2022-10-17 07:25
2513
With New Commitment, Gates Foundation Joins Call to Help End Polio
BERLIN, Oct. 17, 2022 /PRNewswire/ -- Today at the World Health Summit, the Bill & Melinda Gates Foundation announced it will commit$1.2 billion to support efforts to end all forms of polio globally. The announcement was made ahead of a key pledging moment that will be co-hosted by Germany and the...
2022-10-17 01:30
3464
PENTAX Medical launches the C2 CryoBalloon(TM) Ablation System in Canada for the treatment of Barrett's Esophagus.
MISSISSAUGA, ON, Oct. 14, 2022 /PRNewswire/ -- PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy solutions, announced today the Canadian launch of the C2 CryoBalloon™ Ablation System for the treatment of Barrett's Esophagus. "With the launch of C2 CryoBalloon A...
2022-10-15 03:57
2442
Tianfu International Biocity: Build Global Bioindustry-city
CHENGDU, China, Oct. 14, 2022 /PRNewswire/ -- On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten project agreements totalling nearly 9B CNY in value and covering modern biopharmaceuticals, innovative chemical drugs, sophisticated medical apparatuses and other important f...
2022-10-14 20:48
2002
Fosun Pharma's MSCI ESG Rating Upgraded to A
SHANGHAI, Oct. 13, 2022 /PRNewswire/ -- The world's leading index company Morgan Stanley Capital International ("MSCI") recently announced its latest annual Environmental, Social and Governance ("ESG") rating results. In recognition of its outstanding performance in ESG,MSCI upgraded the ESG rati...
2022-10-14 08:26
4080
Health Canada Approves Illuccix® for Prostate Cancer Imaging
MELBOURNE, Australia, Oct. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that Health Canada has approved Illuccix® [kit for the preparation of gallium (68Ga) gozetotide injection] for use in staging and re-staging intermediate and high-risk prost...
2022-10-14 08:21
2718
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting
SUZHOU, China, Oct. 14, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it will present ...
2022-10-14 08:00
3594
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy
Australia now open for study of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying t...
2022-10-13 22:25
2429
3M V.A.C. Therapy negative pressure wound therapy achieves key medical evidence milestone, surpassing 2,000 peer-reviewed medical journal studies published
ST. PAUL, Minn., Oct. 13, 2022 /PRNewswire/ -- 3M Health Care's Medical Solutions Division today announced its3M™ V.A.C.® Therapy negative pressure wound therapy (NPWT) has surpassed a clinical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the fir...
2022-10-13 21:10
2594
First in North America: Jolly Good Hosts Clinical VR Multi Seminar in Boston, Aiming for Mass Production of UGC Medical VR
At the Boston Convention Center on Tuesday, October 25, 2022 TOKYO, Oct. 13, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as "Jolly Good") will hold a large-scale seminar on clinical training VR produced by the UGC* medical VR platform "JOLLYGO...
2022-10-13 21:00
2249
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx
SEOUL, South Korea, Oct. 13, 2022 /PRNewswire/ -- According to International Diabetes Federation, approximately 537 million adults (20-79 years) are living with diabetes worldwide and 206 million adults of the Western Pacific region includingChina, Japan, and South Korea have diabetes in 2021. St...
2022-10-13 21:00
2248
Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day
WUHAN, China and SAN DIEGO, Calif., Oct. 13, 2022 /PRNewswire/ -- October 13th is World Sight Day.Today, Neurophth Therapeutics, Inc. has a special interview with Dr.Satoshi Kashii, Professor of Visual Sciences and Ophthalmology, Aichi Shukutoku University, President of Asian Neuro-Ophthalmology ...
2022-10-13 20:30
3266
Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination
These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. HUNTINGDON VALLEY, Pa., Oct. 13...
2022-10-13 20:00
1938
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific
* Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore * Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma's manufacturing capacity by up ...
2022-10-13 19:25
2133
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
61208
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
56639
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
54256
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
23716
